Skip to content
10-Q

Quarterly Report

TScan Therapeutics, Inc. TCRX

0000950170-25-106919

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 129.73M sh
Shares Diluted Q2 2025 · Jun 30, 2025 129.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 113.43M sh
Shares Diluted Q2 2025 · Jun 30, 2024 104.15M sh
Capex Q2 2025 · Jun 30, 2025 $2.81M
Capex Q2 2025 · Jun 30, 2024 $1.57M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$70.85M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$55.49M
Long Term Debt Q2 2025 · Jun 30, 2025 $32.3M
Long Term Debt Q2 2025 · Dec 31, 2024 $32.07M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $169.39M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $178.69M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $242.16M
Stockholders Equity Q2 2025 · Jun 30, 2025 $176.71M
Stockholders Equity Q2 2025 · Mar 31, 2025 $210.2M
Stockholders Equity Q2 2025 · Dec 31, 2024 $240.97M
Stockholders Equity Q2 2025 · Jun 30, 2024 $255.22M
Stockholders Equity Q2 2025 · Mar 31, 2024 $122.97M
Stockholders Equity Q2 2025 · Dec 31, 2023 $150.87M
Current Liabilities Q2 2025 · Jun 30, 2025 $31.32M
Current Liabilities Q2 2025 · Dec 31, 2024 $35.96M
Total Liabilities Q2 2025 · Jun 30, 2025 $121.85M
Total Liabilities Q2 2025 · Dec 31, 2024 $130.15M
Current Assets Q2 2025 · Jun 30, 2025 $221.13M
Current Assets Q2 2025 · Dec 31, 2024 $292.72M
Total Assets Q2 2025 · Jun 30, 2025 $298.56M
Total Assets Q2 2025 · Dec 31, 2024 $371.12M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.55
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2025 −$0.28
Eps Basic Q2 2025 · Jun 30, 2025 −$0.55
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2024 −$0.59
Sga Expense Q2 2025 · Jun 30, 2025 $9.1M
Sga Expense Q2 2025 · Jun 30, 2025 $17.73M
Sga Expense Q2 2025 · Jun 30, 2024 $7.77M
Sga Expense Q2 2025 · Jun 30, 2024 $14.86M
Rd Expense Q2 2025 · Jun 30, 2025 $32.63M
Rd Expense Q2 2025 · Jun 30, 2025 $62.42M
Rd Expense Q2 2025 · Jun 30, 2024 $26.88M
Rd Expense Q2 2025 · Jun 30, 2024 $51.73M
Net Income Q2 2025 · Jun 30, 2025 −$36.95M
Net Income Q2 2025 · Jun 30, 2025 −$71.08M
Net Income Q2 2025 · Jun 30, 2024 −$31.66M
Net Income Q2 2025 · Jun 30, 2024 −$61.8M
Operating Income Q2 2025 · Jun 30, 2025 −$38.65M
Operating Income Q2 2025 · Jun 30, 2025 −$74.9M
Operating Income Q2 2025 · Jun 30, 2024 −$34.11M
Operating Income Q2 2025 · Jun 30, 2024 −$65.49M
Revenue Q2 2025 · Jun 30, 2025 $3.08M
Revenue Q2 2025 · Jun 30, 2025 $5.25M
Revenue Q2 2025 · Jun 30, 2024 $536K
Revenue Q2 2025 · Jun 30, 2024 $1.1M